关注
Katy Ovington
Katy Ovington
Dyne Therapeutics
在 dyne-tx.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Emergence and evolution of a prevalent new SARS-CoV-2 variant in the United States
AA Pater, MS Bosmeny, CL Barkau, KN Ovington, R Chilamkurthy, ...
BioRxiv, 2021.01. 11.426287, 2021
432021
High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples
AA Pater, MS Bosmeny, AA White, RJ Sylvain, SB Eddington, ...
Journal of biological methods 8 (COVID 19 Spec Iss), 2021
272021
Systematic microsatellite repeat expansion cloning and validation
KJ Rohilla, KN Ovington, AA Pater, M Barton, AJ Henke, KT Gagnon
Human genetics 139, 1233-1246, 2020
62020
Emergence and evolution of a prevalent new SARS-CoV-2 variant in the United States. bioRxiv. 2021
AA Pater, MS Bosmeny, CL Barkau, KN Ovington, R Chilamkurthy, ...
https://www. biorxiv. org/content/10.1101/2021.01 11, v2, 2021
52021
Sequencing-guided design of genetically encoded small RNAs targeting CAG repeats for selective inhibition of mutant huntingtin
MA Parasrampuria, AA White, R Chilamkurthy, AA Pater, F El-Azzouzi, ...
Molecular Therapy-Nucleic Acids 35 (2), 2024
2024
C9ORF72 ALS/FTD Molecular Disease Mechanism and Nucleic Acid Therapeutics
K Ovington
Southern Illinois University at Carbondale, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–6